Opioid Receptors in Heart Membranes Signal Through G-Proteins to Regulate Heart Cell Activity
All three opioid receptor types (mu, delta, kappa) are present in cardiac membranes and signal through G-protein coupled pathways that inhibit adenylyl cyclase, revealing the heart's own opioid signaling system.
Quick Facts
What This Study Found
Mu, delta, and kappa opioid receptors in cardiac sarcolemma activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase, confirming a complete opioid signaling pathway in the heart.
Key Numbers
How They Did This
Highly purified canine cardiac sarcolemmal membranes were analyzed for opioid receptor binding, G protein activation (GTPase), and adenylyl cyclase inhibition using selective agonists for each receptor type.
Why This Research Matters
Confirming functional opioid receptors and their signaling pathways in the heart opens the door to understanding how opioid peptides protect cardiac tissue during stress and ischemia.
The Bigger Picture
The cardiac opioid system is now recognized as important for cardioprotection during heart attacks. This study established the molecular machinery that makes this protection possible.
What This Study Doesn't Tell Us
In vitro study using isolated canine cardiac membranes. The functional consequences of this signaling in intact hearts were not assessed.
Questions This Raises
- ?Could selective cardiac opioid receptor activation protect the heart during ischemia?
- ?Do cardiac opioid receptor levels change with heart disease?
Trust & Context
- Key Stat:
- Complete cardiac opioid system Mu, delta, and kappa opioid receptors all present and functional in purified heart cell membranes
- Evidence Grade:
- Moderate in vitro evidence with rigorous biochemical characterization in highly purified membrane preparations.
- Study Age:
- Published in 1996, this study provided key biochemical evidence for the cardiac opioid system that is now well-established.
- Original Title:
- Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.
- Published In:
- Naunyn-Schmiedeberg's archives of pharmacology, 354(5), 643-9 (1996)
- Authors:
- Niroomand, F, Mura, R A, Piacentini, L, Kübler, W
- Database ID:
- RPEP-00374
Evidence Hierarchy
Frequently Asked Questions
Why does the heart have opioid receptors?
The heart's opioid receptors are part of a built-in protective system. When activated by endogenous opioid peptides during stress or ischemia, they trigger signaling pathways that help heart cells survive oxygen deprivation.
What is adenylyl cyclase inhibition?
Adenylyl cyclase is an enzyme that produces cAMP — a molecule that speeds up heart rate and increases contractile force. When opioid receptors inhibit this enzyme, they essentially calm the heart, reducing its oxygen demand during stress.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00374APA
Niroomand, F; Mura, R A; Piacentini, L; Kübler, W. (1996). Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.. Naunyn-Schmiedeberg's archives of pharmacology, 354(5), 643-9.
MLA
Niroomand, F, et al. "Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.." Naunyn-Schmiedeberg's archives of pharmacology, 1996.
RethinkPeptides
RethinkPeptides Research Database. "Opioid receptor agonists activate pertussis toxin-sensitive ..." RPEP-00374. Retrieved from https://rethinkpeptides.com/research/niroomand-1996-opioid-receptor-agonists-activate
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.